Back

SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathway

Chen, D.-Y.; Khan, N.; Close, B. J.; Goel, R. K.; Blum, B.; Tavares, A. H.; Kenney, D.; Conway, H. L.; Ewoldt, J. K.; Kapell, S.; Chitalia, V. C.; Crossland, N. A.; Chen, C. S.; Kotton, D. N.; Baker, S. C.; Connor, J. H.; Douam, F.; Emili, A.; Saeed, M.

2020-10-28 microbiology
10.1101/2020.10.27.358259 bioRxiv
Show abstract

SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we performed global proteomic analysis of the virus-host interface in a newly established panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs. This revealed universal inhibition of interferon signaling across cell types following SARS-CoV-2 infection. We performed systematic analyses of the JAK-STAT pathway in a broad range of cellular systems, including immortalized cell lines and primary-like cardiomyocytes, and found that several pathway components were targeted by SARS-CoV-2 leading to cellular desensitization to interferon. These findings indicate that the suppression of interferon signaling is a mechanism widely used by SARS-CoV-2 in diverse tissues to evade antiviral innate immunity, and that targeting the viral mediators of immune evasion may help block virus replication in patients with COVID-19.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.